Home » Topics » BioWorld Science

BioWorld Science
RSS

TOTUM-854 prevents the development of experimental arterial hypertension

Nov. 18, 2021

Novel acute lung injury murine model unveils neuronal damage

Nov. 18, 2021

Shanghai Licheng Biotechnology divulges CLRN3-targeting nucleic acids

Nov. 18, 2021

Betta Pharmaceuticals identifies PTPN11 inhibitors

Nov. 18, 2021

GNT Biotech & Medicals presents new HDAC inhibitors

Nov. 18, 2021

Innate checkpoint inhibitor ASD-141 inhibits tumor growth in colon cancer models

Nov. 18, 2021

Gasherbrum Bio patents GLP-1 receptor agonists

Nov. 18, 2021

p53-PHLDA3-Akt signaling as novel therapeutic target in heart failure

Nov. 18, 2021

Medshine Discovery discloses new MAPK inhibitors

Nov. 18, 2021

Novel STING agonist RVU-27065 shows potency in EMT6 breast cancer model

Nov. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...